Journal of Pharmaceutical Health Services Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Influences on interactions between physicians in the public and private sectors and medical representatives in Yemen
ConclusionPhysicians in Yemen consider most of the promotional techniques as normal practice. The article provides empirical evidence for policymakers in developing countries in general, and Yemen specifically, to develop suitable policies and regulations for drug promotion. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Mahmoud A. Al ‐Areefi, Mohamed Izham M. Ibrahim, Mohamed Azmi A. Hassali, Abubakr A. Alfadl Tags: Research Paper Source Type: research

Health expenditure and health services utilization comparison of patients with type 2 diabetes on sodium –glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors: evidence from 2015 to 2016 medical expenditure panel survey
ConclusionSGLT2 inhibitors were associated with significantly higher overall and prescription expenditures compared to DPP4 inhibitors during the study period evaluated. Future studies need to utilize administrative claims data to assess current comparativeness effectiveness trends. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Pranav M. Patel, Varun Vaidya Tags: Research Paper Source Type: research

Anticoagulant drug utilization pattern and their cost analysis: a retrospective study from Saudi Arabia
ConclusionApixaban was the preferred oral anticoagulant among all the studied anticoagulants, although Warfarin is the cheapest. Therapeutic drug monitoring was recommended for Warfarin. The study highlights the importance of more studies to measure the advantages and disadvantages of all types of anticoagulants. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Mohammad Daud Ali, Ayaz Ahmad, Nuzhat Banu, Munfis Patel, Sherihan Ahmad Ghosn, Zainab Eltrafi Tags: Short Communication Source Type: research

Barriers and facilitators to provision of written consumer medicines information among community pharmacists in Malaysia: a cross ‐sectional study
ConclusionsThe key barriers to the provision of CMIL by the community pharmacists appeared to be related to attitudinal factors, while key facilitators appeared to be related to the professional obligations of the community pharmacists. Increased awareness and educational strategies would be important in improving the provision of CMIL by community pharmacists in Malaysia. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Omotayo Fatokun, Xin Yi Mooi, Osama Helweh, Mogana Rajagopal Tags: Short Communication Source Type: research

Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines
ConclusionThe guideline ’s overall quality was judged to be high, and all appraisers recommended its use in practice without modifications. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Eman N. Alhmoud, Raja Barazi, Amr Fahmi, Abdullah Abdu, Alya Higazy, Maguy ElHajj Tags: Short Communication Source Type: research

Factors associated with the level of knowledge about hypertension in Malaysia: A short communication
ConclusionsThere are several factors have a great impact on hypertension knowledge in Malaysia; hence, understanding them makes it possible for the community to change public policies and educational programmes for the population that need it the most. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Ali Haider Mohammed, Bassam Abdul Rasool Hassan, Azyyati Mohd Suhaimi, Ali Blebil, Juman Dujaili Tags: Short Communication Source Type: research

Cost ‐effectiveness of Interventional therapies for management of Treatment‐resistant hypertension: systematic review of pharmacoeconomic studies
ConclusionOverall cost ‐effectiveness of interventional therapies for treatment of TRH was inconclusive based on the current available evidence. Therefore, strong clinical trials and pharmacoeconomic evaluations from different perspectives in various candidate populations are needed to generate adequate clinical and cos t‐effectiveness evidence for using interventional therapies in treatment of treatment resistant hypertension. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Mende Sorato, Majid Davari, Abbas Kebriaeezadeh, Nasim Naderi, Nizal Sarrafzadegan, Tamiru Shibru, Shekoufeh Nikfar, Amanuel Godana Arero Tags: Review Source Type: research

Why healthcare market needs government intervention to improve access to essential medicines and healthcare efficiency: a scoping review from pharmaceutical price regulation perspective
ConclusionRegulating pharmaceutical pricing system is one of the key strategies to ensure access to essential medicines. Countries that have implemented pharmaceutical price regulation system (Germany, the UK, Canada and Iran) have achieved better access to essential medicines. However, the US and Ethiopian health systems that are unregulated concerning pharmaceutical pricing had a great challenge of affordability of essential medicines. Therefore, setting country ‐specific pharmaceutical price regulation system along with additional strategies to improve drug innovation is critical to ensure access to essential medicine...
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Mende Sorato, Majid Davari, Akbar Abdollahi Asl, Fatemeh Soleymani, Abbas Kebriaeezadeh Tags: Review Article Source Type: research

Issue Information
Journal of Pharmaceutical Health Services Research, Volume 11, Issue 4, Page 303-304, November 2020. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Tags: Issue Information Source Type: research

Complexities in pharmaceutical health services research
Journal of Pharmaceutical Health Services Research, Volume 11, Issue 4, Page 305-305, November 2020. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Albert I. Wertheimer Tags: Editorial Source Type: research

Investigating prescribing errors in the emergency department of a large governmental hospital in Jordan
ConclusionA national approach for observing, intervening on and correcting PEs is necessary to improve patient safety. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Derar H. Abdel ‐Qader, Ahmad Z. Al Meslamani, Asma' A. El‐Shara', Najlaa Saadi Ismael, Abdullah Albassam, Penny J. Lewis, Salim Hamadi, Hazim Saleem Abbas, Nadia Al Mazrouei, Osama Mohamed Ibrahim Tags: Research Paper Source Type: research

Healthcare professionals ’ knowledge, perception and practice towards COVID‐19: A cross‐sectional web‐survey
ConclusionsIraqi HCPs have an overall good knowledge towards COVID ‐19. More information should be published from reputable and authentic sources to HCPs. The Ministry of Health in Iraq could take its responsibility to inform the health providers with updated and confirmed information about COVID‐19 prevention and management. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Mohammed I. Aladul, Harith Kh. Al ‐Qazaz, Omer Q. B. Allela Tags: Research Paper Source Type: research

Assessment of medication knowledge among patients with asthma
ConclusionsThese findings highlight the importance of educational programmes that should be conducted in primary healthcare settings, such as community pharmacies, where pharmacists should educate patients about their medication and the importance of adherence. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Basima A. Almomani, Shoroq M. Altawalbeh, Munther S. Alnajjar, Suleiman M. Momany Tags: Research Paper Source Type: research

A retrospective study on prescribing pattern and cost analysis of proton ‐pump inhibitors used among adults of Saudi Arabia
ConclusionIn our study, among all the PPIs Pantoprazole was prescribed to the highest number of patients also it was costliest; hence, their safe and effective use must be warranted. Current study will also help in to develop nation database regarding utilization of proton ‐pump inhibitors. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Mohammad Daud Ali, Ayaz Ahmad Tags: Research Paper Source Type: research

Use and non ‐use of a nationwide patient portal – a survey among pharmacy customers
ConclusionsMost Finnish pharmacy customers use the My Kanta nationwide patient portal. The strongest predictors for use are factors related to internet use. Some pharmacy customers do not use My Kanta despite having the necessary means. The main reason for non ‐use is a lack of need. Customers unable to use My Kanta want to monitor their medication and health information via healthcare professionals. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - November 9, 2020 Category: Drugs & Pharmacology Authors: Maria S ääskilahti, Emma Aarnio, Elina Lämsä, Riitta Ahonen, Johanna Timonen Tags: Research Paper Source Type: research